Living with Haemophilia

por Laffan, Mike
Publicado en J R Coll Physicians Lond (1995)

Drug therapy in anticoagulation: which drug for which patient?

por Millar, Carolyn M, Laffan, Mike A
Publicado en Clin Med (Lond) (2017)

Corrigendum: Drug therapy in anticoagulation: which drug for which patient?

por Millar, Carolyn M, Laffan, Mike A
Publicado en Clin Med (Lond) (2017)

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

por Arachchillage, Deepa R. J., Laffan, Mike
Publicado en J Thromb Haemost (2020)

Debate: Should the dose or duration of anticoagulants for the prevention of venous thrombosis be increased in patients with COVID‐19 while we are awaiting the results of clinical t...

por Gomez, Keith, Laffan, Mike, Bradbury, Charlotte
Publicado en Br J Haematol (2020)

Von Willebrand Factor, Angiodysplasia and Angiogenesis

por Randi, Anna M., Laffan, Mike A., Starke, Richard D.
Publicado 2013

Genetically Determined Platelet Count and Risk of Cardiovascular Disease: Mendelian Randomization Study

por Gill, Dipender, Monori, Grace, Georgakis, Marios K., Tzoulaki, Ioanna, Laffan, Mike
Publicado en Arterioscler Thromb Vasc Biol (2018)

Evaluation of von Willebrand factor concentrates by platelet adhesion to collagen using an in vitro flow assay

por Riddell, Anne, Vinayagam, Saravanan, Gomez, Keith, Laffan, Mike, McKinnon, Tom
Publicado en Res Pract Thromb Haemost (2018)

Thrombolysis restores perfusion in COVID‐19 hypoxia

por Arachchillage, Deepa J., Stacey, Arthur, Akor, Frances, Scotz, Martin, Laffan, Mike
Publicado en Br J Haematol (2020)

Platelet dysfunction associated with ponatinib, a new pan BCR-ABL inhibitor with efficacy for chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitor therapy

por Neelakantan, Pratap, Marin, David, Laffan, Mike, Goldman, John, Apperley, Jane, Milojkovic, Dragana
Publicado 2012

Genetically Proxied Inhibition of Coagulation Factors and Risk of Cardiovascular Disease: A Mendelian Randomization Study

por Yuan, Shuai, Burgess, Stephen, Laffan, Mike, Mason, Amy M., Dichgans, Martin, Gill, Dipender, Larsson, Susanna C.
Publicado en J Am Heart Assoc (2021)

Anticoagulation with argatroban in patients with acute antithrombin deficiency in severe COVID‐19

por Arachchillage, Deepa J., Remmington, Christopher, Rosenberg, Alex, Xu, Tina, Passariello, Maurizio, Hall, Donna, Laffan, Mike, Patel, Brijesh V.
Publicado en Br J Haematol (2020)

A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF

por Zanardelli, Sara, Chion, Alain C. K., Groot, Evelyn, Lenting, Peter J., McKinnon, Thomas A. J., Laffan, Mike A., Tseng, Michelle, Lane, David A.
Publicado 2009

Practical guidance for the management of adults with immune thrombocytopenia during the COVID‐19 pandemic

por Pavord, Sue, Thachil, Jecko, Hunt, Beverley J., Murphy, Mike, Lowe, Gillian, Laffan, Mike, Makris, Mike, Newland, Adrian C., Provan, Drew, Grainger, John D., Hill, Quentin A.
Publicado en Br J Haematol (2020)

Associations of genetically determined iron status across the phenome: A mendelian randomization study

por Gill, Dipender, Benyamin, Beben, Moore, Luke S. P., Monori, Grace, Zhou, Ang, Koskeridis, Fotios, Evangelou, Evangelos, Laffan, Mike, Walker, Ann P., Tsilidis, Konstantinos K., Dehghan, Abbas, Elliott, Paul, Hyppönen, Elina, Tzoulaki, Ioanna
Publicado en PLoS Med (2019)

Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells

por Starke, Richard D., Paschalaki, Koralia E., Dyer, Clare E. F., Harrison-Lavoie, Kimberly J., Cutler, Jacqueline A., McKinnon, Thomas A. J., Millar, Carolyn M., Cutler, Daniel F., Laffan, Mike A., Randi, Anna M.
Publicado 2013

Endothelial von Willebrand factor regulates angiogenesis

por Starke, Richard D., Ferraro, Francesco, Paschalaki, Koralia E., Dryden, Nicola H., McKinnon, Thomas A. J., Sutton, Rachel E., Payne, Elspeth M., Haskard, Dorian O., Hughes, Alun D., Cutler, Daniel F., Laffan, Mike A., Randi, Anna M.
Publicado 2011

The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing

por Ishihara, Jun, Ishihara, Ako, Starke, Richard D., Peghaire, Claire R., Smith, Koval E., McKinnon, Thomas A. J., Tabata, Yoji, Sasaki, Koichi, White, Michael J. V., Fukunaga, Kazuto, Laffan, Mike A., Lutolf, Matthias P., Randi, Anna M., Hubbell, Jeffrey A.
Publicado en Blood (2019)

COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects

por Smadja, David M., Mentzer, Steven J., Fontenay, Michaela, Laffan, Mike A., Ackermann, Maximilian, Helms, Julie, Jonigk, Danny, Chocron, Richard, Pier, Gerald B., Gendron, Nicolas, Pons, Stephanie, Diehl, Jean-Luc, Margadant, Coert, Guerin, Coralie, Huijbers, Elisabeth J. M., Philippe, Aurélien, Chapuis, Nicolas, Nowak-Sliwinska, Patrycja, Karagiannidis, Christian, Sanchez, Olivier, Kümpers, Philipp, Skurnik, David, Randi, Anna M., Griffioen, Arjan W.
Publicado en Angiogenesis (2021)